EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Associations of Chronic Lymphocytic Leukemia (CLL) Susceptibility Variants Across the CLL Etiologic Continuum

Raphael Mwangi iD, Geffen Kleinstern iD, Dennis Robinson, Aaron D Norman iD, Kari G Rabe iD, Janet E Olson, Yuan Yao iD, Nicholas J Boddicker, Rosalie Griffin iD, Esteban Braggio iD, James R Cerhan iD, Curtis A Hanson und 4 weitere

Cancers · 05.11.2026 · 18 (21) · 3556

DOI: 10.3390/cancers18213556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 05.11.2026. Verfasst von Raphael Mwangi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Computational Biology, Mayo Clinic, Rochester, MN 55902, USA. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Low-count monoclonal B-cell lymphocytosis (LC-MBL) is a precursor to chronic lymphocytic leukemia (CLL). Forty-one inherited susceptibility variants for CLL have been reported, but whether these variants impact CLL, through the initiation of the clone (LC-MBL) or progression of LC-MBL to CLL, is not well characterized.

Methods

We evaluated 41 previously reported CLL susceptibility variants and the CLL polygenic risk score (CLL-PRS, a weighted score of the 41 variants) among a study of 8322 individuals who screened negative for MBL based on eight-color flow cytometry, 1601 individuals who screened positive for LC-MBL, and 2606 CLL patients. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CI) for LC-MBL compared with MBL-negative individuals and for CLL compared with LC-MBL (herein labeled progression). Models were adjusted for age, sex, and genetic principal components.

Results

Of the 41 variants, 22 (54%) were associated with LC-MBL and 20 (49%) with progression (all p < 0.05). The ORs for eight variants differed between LC-MBL risk and progression (false discovery rate, FDR < 0.05), including two (rs6708784, 2q13; rs391855, 16q24.1) with associations in opposite directions. The CLL-PRS was associated with both LC-MBL (OR = 1.77, 95% CI: 1.66–1.88, p = 3.7 × 10−68) and progression (OR = 1.45, 95% CI: 1.35–1.56, p = 8.1 × 10−24).

Conclusions

The effects of individual CLL-risk variants vary across the etiological continuum of disease with a subset associated with clonal initiation of LC-MBL and clonal progression to different degrees, or even in opposite directions. The CLL-PRS may help identify individuals at elevated risk for both LC-MBL and progression to CLL.

Schlagwörter

Stichwörter der Autor:innen

chronic lymphocytic leukemiamonoclonal B-cell lymphocytosispolygenic risk scoresusceptibility variants

Autor:innen und Institutionen

  • Division of Computational Biology, Mayo Clinic, Rochester, MN 55902, USA.
  • Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN 55902, USA.
  • Faculty of Social Welfare & Health Sciences, School of Public Health, University of Haifa, Haifa 3498838, Israel.
  • Division of Epidemiology, Mayo Clinic, Rochester, MN 55902, USA.
  • Division of Hematology, Mayo Clinic, Rochester, MN 55902, USA.
  • Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

ORCID-Profile: Raphael Mwangi, Geffen Kleinstern, Aaron D Norman, Kari G Rabe, Yuan Yao, Rosalie Griffin, Esteban Braggio, James R Cerhan, Susan L Slager

Förderung

  • NIA NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Mwangi, R., Kleinstern, G., Robinson, D., Norman, A. D., Rabe, K. G., Olson, J. E., Yao, Y., Boddicker, N. J., Griffin, R., Braggio, E., Cerhan, J. R., Hanson, C. A., Vachon, C. M., Parikh, S. A., Shanafelt, T. D., & Slager, S. L. (2026). Associations of Chronic Lymphocytic Leukemia (CLL) Susceptibility Variants Across the CLL Etiologic Continuum. Cancers, 18(21), 3556. https://doi.org/10.3390/cancers18213556

Vancouver

Mwangi R, Kleinstern G, Robinson D, Norman AD, Rabe KG, Olson JE, et al. Associations of Chronic Lymphocytic Leukemia (CLL) Susceptibility Variants Across the CLL Etiologic Continuum. Cancers. 2026;18(21):3556. doi:10.3390/cancers18213556

BibTeX
@article{Mwangi2026,
  author = {Mwangi, Raphael and Kleinstern, Geffen and Robinson, Dennis and Norman, Aaron D and Rabe, Kari G and Olson, Janet E and Yao, Yuan and Boddicker, Nicholas J and Griffin, Rosalie and Braggio, Esteban and Cerhan, James R and Hanson, Curtis A and Vachon, Celine M and Parikh, Sameer A and Shanafelt, Tait D and Slager, Susan L},
  title = {Associations of Chronic Lymphocytic Leukemia (CLL) Susceptibility Variants Across the CLL Etiologic Continuum},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {21},
  pages = {3556},
  doi = {10.3390/cancers18213556}
}
Kostenlos starten →